Table 1.
Baseline Characteristics of Patients With and Without SARS‐CoV‐2 Viremia
| COVID‐19 Without Viremia (n=75) | COVID‐19 With Viremia (n=48) | P Value | |
|---|---|---|---|
| Age, y | 58.4±16.3 | 61.5±13.2 | 0.26 |
| Male sex | 38 (50.7%) | 33 (68.8%) | 0.048 |
| White | 46 (61.3%) | 22 (45.8%) | 0.09 |
| Body mass index, kg/m2 | 27.9±4.0 | 29.0±7.2 | 0.28 |
| Diabetes mellitus | 7 (9.3 %) | 14 (29.2%) | 0.004 |
| Hypertension | 21 (28.4%) | 18 (38.3%) | 0.26 |
| Cardiovascular disease | 11 (14.7%) | 7 (14.6%) | 0.99 |
| Pulmonary disease | 2 (2.7 %) | 4 (8.3 %) | 0.15 |
| Chronic kidney disease | 6 (8.0 %) | 3 (6.3 %) | 0.72 |
| RAAS‐inhibitors use | 18 (24.0%) | 17 (35.4%) | 0.17 |
| Smoking | 5 (6.7 %) | 1 (2.1 %) | 0.25 |
| Symptom duration, d | 9.7±5.0 | 8.8±3.6 | 0.28 |
| Fever | 59 (78.7%) | 41 (85.4%) | 0.35 |
| Cough | 58 (77.3%) | 40 (83.3%) | 0.42 |
| Dyspnea | 48 (64.0%) | 38 (79.2%) | 0.07 |
| Temperature (C⁰) | 38.1±0.9 | 38.2±0.9 | 0.54 |
| Heart rate, /min | 90.0±18.4 | 90.3±13.6 | 0.91 |
| Respiratory rate, /min | 25.7±8.2 | 28.4±9.0 | 0.09 |
| Blood pressure, mm Hg | 134.5±19.2 | 128.2±17.2 | 0.06 |
| Oxygen saturation, % | 94.2±3.0 | 90.7±7.8 | <0.001 |
RAAS indicates renin‐angiotensin‐aldosterone‐system.